GL earnings analysis
What we found in GL's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Globe Life reported a strong Q1 2026, with revenue of $1.56 billion, exceeding estimates, while EPS came in at $3.43, just below expectations. The company raised its full-year EPS guidance, reflecting robust premium and net sales growth, particularly in the health insurance segment, despite rising operational costs.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue Exceeds Estimates
- Q1 2026 revenue was $1.56 billion, beating estimates by $6 million.
- EPS Surge
- Reported diluted EPS increased to $3.43, a 12% increase from $3.07 a year prior.
- Strong Segment Performance
- Health insurance premiums grew 13% YoY, contributing significantly to overall growth.
- Increased Shareholder Returns
- The company repurchased shares costing $203 million at an average price of $141.24.
- Higher Book Value
- Book value per share climbed to $77.03, reflecting a 19% YoY increase.
- Robust Net Operating Income
- Net operating income rose to $274 million, marking a 5.5% increase from the previous year.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Litigation Expenses
- Legal proceedings expenses recorded $1.8 million, potentially impacting net income.
- Investment Market Volatility
- Net unrealized loss on investments increased from $1.2 billion to $1.6 billion since year-end due to market rate changes.
- Operational Cost Increases
- Operating expenses rose to $113.7 million, a 5% increase driven by administrative costs.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $3.43
- Gross margin
- 42.5%
- Operating margin
- 23.7%
- Segment
- Life Insurance
- Segment
- Health Insurance
What they said about what is next.
EPS guidance raised to $15.40-$15.90 for FY 2026, up $0.35 at the midpoint.
The filing reads better than the one before it.
What came before.
- 10-K · February 25, 2026
- Globe Life reports steady premium and premium-in-force growth with total annualized premium in force of $3,421,143 (in thousands) in 2025 and health annualized premium rising to $1,649,670 (in thousands) in 2025. The…
- 10-Q · May 7, 2025
- Globe Life reported quarterly revenue of $1,480,422 (thousands) and diluted EPS of $3.01 for the three months ended March 31, 2025. Premiums grew year-over-year (total premium $1,199,654 vs $1,145,284) and operating…
- 10-Q · November 6, 2024
- Globe Life reported Q3 results with total revenue of $1,455,407 (thousands) (up from $1,384,118 in Q3 2023) and diluted EPS of $3.44 (up from $2.68). Operating profitability improved (income before income taxes $376,958…
- 10-K · February 28, 2024
- Globe Life positions itself as a niche life and supplemental health insurer with diversified distribution (direct-to-consumer, exclusive and independent agents) and growing premium in force. The 10-K shows scale in…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing GL makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever